They may think they are being conservative, but by not updating the profit forecast post acquisition, they are basically downgrading the profit forecast from the rest of the business.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025